Advertisement

Similarity-Based Integrated Method for Predicting Drug-Disease Interactions

  • Yan-Zhe Di
  • Peng Chen
  • Chun-Hou ZhengEmail author
Conference paper
Part of the Lecture Notes in Computer Science book series (LNCS, volume 10955)

Abstract

The in silico prediction of potential interactions between drugs and disease is of core importance for effective drug development. Previous studies indicated that computational approaches for discovering novel indications of drugs by integrating information from multiple types have the potential to provide great insights to the complex relationships between drugs and diseases at a system level. However, each single data source is important in its own way and integrating data from different sources remains a challenging problem. In this article, we have proposed a new similarity combination method to integrate drug-disease association, drug chemical information, drug target domain information and target annotation information for drug repositioning. Specifically, we introduce interaction profiles of drugs (and of diseases) in a network, which are treated as label information and is used for model learning of new candidates. We compute multiple drugs and diseases similarity on these features, and use an integrated classifier for predicting drug-disease interactions. Comprehensive experimental results show that the proposed approach can serve as a useful tool in drug discovery to efficiently identify novel. Case studies show that our model has good performance.

Keywords

Drug-disease interaction Drug repositioning Similarity matrix 

Notes

Acknowledgment

This study was supported by the National Natural Science Foundation of China (No. 61672037), the Key Project of Anhui Provincial Education Department (No. KJ2017ZD01), and the Key Project of Academic Funding for Top-notch Talents in University (No. gxbjZD2016007).

References

  1. 1.
    Lipinski, C., Lombardo, F., Dominy, B., Feeney, P.: Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 64, 4–17 (2012)CrossRefGoogle Scholar
  2. 2.
    Wang, W., Yang, S., Zhang, X., Li, J.: Drug repositioning by integrating target information through a heterogeneous network model. Bioinformatics 30, 2923–2930 (2014)CrossRefGoogle Scholar
  3. 3.
    Wu, Z., Wang, Y., Chen, L.: Network-based drug repositioning. Mol. BioSyst. 9, 1268–1281 (2013)CrossRefGoogle Scholar
  4. 4.
    Liang, X., Zhang, P., Yan, L., Fu, Y., Peng, F.: LRSSL: predict and interpret drug-disease associations based on data integration using sparse subspace learning. Bioinformatics 33, 1187–1196 (2017)CrossRefGoogle Scholar
  5. 5.
    van Driel, M., et al.: A text-mining analysis of the human phenome. Eur. J. Hum. Genet. 14, 535–542 (2006)CrossRefGoogle Scholar
  6. 6.
    Yamanishi, Y., Araki, M., Gutteridge, A.: Prediction of drug-target interaction networks from the integration of chemical and genomic spaces. Bioinformatics 24(2), 32–40 (2008)Google Scholar
  7. 7.
    Liaw, A., Wiener, M.: Classification and regression by randomforest. R News. 2, 18–22 (2002)Google Scholar
  8. 8.
    Davis, A., et al.: The comparative toxicogenomics database’s 10th year anniversary: update 2015. Nucleic Acids Res. 43, D914–D920 (2014)CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.College of Computer Science and TechnologyAnhui UniversityHefeiChina
  2. 2.Co-Innovation Center for Information Supply & Assurance TechnologyAnhui UniversityHefeiChina
  3. 3.Institute of Material Science and Information TechnologyAnhui UniversityHefeiChina

Personalised recommendations